LexisNexis Risk Solutions to Speak on New Cross-Industry Platform Approach to Improve Provider Data Quality at AHIP 2019

ATLANTA, June 12, 2019 /PRNewswire/ — LexisNexis® Risk Solutions announced that it will present the constructs for a new cross-industry platform approach to address provider data quality at AHIP Institute & Expo 2019. Josh Schoeller, senior vice president and general manager, LexisNexis Risk Solutions and Art Wrightson, president, Sorsee Consulting, will discuss how cross-industry collaboration and the application of analytics can help health plans look beyond provider data accuracy towards a more comprehensive solution to this ongoing industry challenge. The presentation will take place on Wednesday, June 19, from 5 – 5:50 pm in Room 105, Level 1, and will include the following:  

  • Limitations of current approaches,
  • Role of technology and analytics,
  • Importance of ongoing validation and augmentation, and
  • The value of considering a multi-stakeholder approach.

Additionally, LexisNexis Risk Solutions will hold short educational sessions in its booth #724 on the following topics:

  • Tips for leveraging provider data across the health plan enterprise to boost efficiency, member experience and compliance:

Wednesday, June 19th, 3:40 – 3:55 pm
Thursday, June 20th, 8:30 – 8:45 am

  • Addressing the ethical use of social determinants of health (SDOH) in health care:

Wednesday, June 19th, 3:55 – 4:10 pm
Thursday, June 20th, 8:45 – 9:00 am

The SDOH-focused session will put forth guiding principles when considering the use of SDOH. Attendees will learn the proposed use cases for this data and view examples of how it can be leveraged to achieve optimal health and wellness outcomes.

Please use this link to view the AHIP Institute & Expo 2019 agenda. To learn more about LexisNexis® Risk Solutions – Health Care, visit https://risk.lexisnexis.com/healthcare.

About LexisNexis Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers across industries. For more information, please visit www.risk.lexisnexis.com and www.relx.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/lexisnexis-risk-solutions-to-speak-on-new-cross-industry-platform-approach-to-improve-provider-data-quality-at-ahip-2019-300865882.html

SOURCE LexisNexis Risk Solutions

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

18 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

18 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

18 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

18 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

18 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

18 hours ago